// App-Quantinova.ai

POS0305 (2021) : PHYSICIAN AND PATIENT ATTITUDES TOWARDS TREAT-TO-TARGET, ITS IMPLEMENTATION AND STATED TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A REAL-WORLD SETTING ACROSS EUROPE

Researchers

Presenter

  • B. Fautrel

Principal Investigators

  • R. Caporali

  • E. Holdsworth

  • M. Khalid

  • M. Moore

  • K. Van Beneden

  • Y. Piette

  • S. Romero-Yuste

  • J. Broen

  • P. C. Taylor

Medical Centers

  • Sorbonne Université – INSERM; AP-HP, Pitié Salpêtrière Hospital, Rheumatology department, Paris, France

  • University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy

  • G. Pini Hospital, Clinical Rheumatology Unit, Milan, Italy

  • Adelphi Real World, Bollington, United Kingdom

  • Galapagos NV, Evidence Generation & Epidemiology, Mechelen, Belgium

  • Gilead Sciences Europe Ltd, Global Medical Affairs, Uxbridge, United Kingdom

  • Galapagos NV, Medical Affairs, Mechelen, Belgium

  • AZ Sint-Jan Brugge - Oostende AV, Department of Rheumatology, Bruges, Belgium

  • Complexo Hospitalario Universitario de Pontevedra, Gastroenterology Department, Pontevedra, Spain

  • Maxima Medical Center, Regional Rheumatology Center, Eindhoven, Netherlands

  • University of Oxford, Botnar Research Centre, Oxford, United Kingdom

Locations

  • France

  • Italy

  • United Kingdom

  • Belgium

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Galapagos

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved